Introduction
Polymorph screening and co-crystal formation are useful strategies to find new solid forms of active pharmaceutical ingredients (APIs), in order to alter/improve their physical properties without changing their chemical identities or biological activities. 1 Most commonly APIs have hydrogen bonding donor and acceptor groups that are involved in the binding of the co-crystal former (CCF), e.g., carboxylic acids and aromatic nitrogen atoms have been proven particularly reliable moieties in hydrogen bonding (HB) driven formation of API-CCF adducts. 2 On the other hand, the design of pharmaceutical co-crystals involving APIs devoid of strong hydrogen bond donor sites is quite challenging.
Halogen atoms are frequently present in drugs molecules and we considered that they can be used to drive the formation of pharmaceutical co-crystals if the halogen bonding 3 (XB) is used. Recently we demonstrated that the iodoalkyne moiety of an API can be successfully used to prepare halogen-bonded cocrystals with improved physicochemical properties. 4 In this paper we describe a further case where the same moiety drives the formation of co-crystals with neutral and anionic partners. More important, we describe how the iodoalkyne moiety can play an active role in the formation of different polymorphs of an API.
Haloprogin 1 (1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy] benzene) is the API of antimycotic topical drugs with brand names of Halotex®, Mycanden®, Mycilan® and Polik® (Scheme 1). 5 No structures involving 1 are reported in the Cambridge Structural Database (CSD), 6 consistent with the fact that it may represent a difficult challenge if a standard approach for polymorph and co-crystal formation is pursued since it does not contain any of the functional groups typically required for a HB-based strategy. On the other hand, an iodine atom bound to the sphybridised carbon atom displays a particularly anisotropic distribution of its electron density. 7 A region of remarkably positive electrostatic potential, the so-called positive σ-hole, 8 is present on the outermost surface of the iodine atom and along the extension of the C-I covalent bond. This specific feature makes the iodoalkyne moiety a very good XB donor site.
9, 10 We reasoned that the presence in 1 of one efficient XB donor site along with the absence of strong HB donor sites represents a unique opportunity to explore the obtainment of new cocrystals based on XB. In addition, the presence in 1 of multiple electron donor sites that may be involved in XB, e.g., the chlorine atoms, the oxygen atom, and the π electrons, may favour the obtainment of different polymorphs and allow for a quite rich structural landscape for the pure API. Three polymorphs 1a, 1b, and 1c of haloprogin are described here. As far as co-crystals of 1 are concerned, we obtained a neutral co-crystal 4 with 4,4'-bipyridine (2) and two ionic co-crystals 5a and 5b with tetra n-butylammonium iodide (3a) and chloride (3b). 11 The studied CCFs were chosen in order to cover both neutral and anionic electron density donor sites, which are both well represented in the FDA-GRAS
12
(Food and Drug Administration-Generally Recognized As Safe) list. All obtained solid forms of 1 (polymorphs and co-crystals) were fully characterized by using various analytical techniques, such as single-crystal and powder X-ray diffraction analyses, FT-IR, differential scanning calorimetry (DSC), and solid state (SS) NMR.
Experimental Section Materials
Solvents and reagents were purchased from Sigma Aldrich at high purity grade and used without further purification. haloprogin was synthesized in two steps according to the procedure reported by Fellig et al. 13 (see ESI). Solution NMR spectra were collected on a Bruker AV400 spectrometer. Single crystals of polymorphs 1a and 1b were obtained by slow evaporation methods. Single crystals of polymorphs 1b and 1c were obtained via both slow evaporation and sublimation. Cocrystals of 4 were obtained by slow evaporation methods. Mechanochemical synthesis of 5a and 5b was performed using a Retsch MM400 ball mill with 5.0 mL vessels, operating at 30 Hz. Corresponding single crystals were obtained by seeding quasi-saturated solutions of 1 and 3a or 3b, respectively (in the appropriate molar ratio) with the powders obtained from ball milling experiments. Vibrational Spectroscopy. IR spectra were collected using a Nicolet Nexus FT-IR spectrometer equipped with Smart Endurance ATR device, and analysed using Omnic software v.7.3. Peak values are given in wavenumbers (cm -1 ) upon automatic assignment. Thermal Analysis. Melting points were collected using a Linkam Hot-Stage microscopy apparatus. Thermal analysis was performed on a Mettler Toledo DSC 823e differential scanning calorimeter. X-ray Crystallography.
A Bruker AXS D8 powder diffractometer was used for all X-ray powder (XRPD) measurements with experimental parameters are as follows: Cu-Kα radiation (λ = 1.54056 Å), scanning interval: 4-40° 2θ.
Step size 0.016°, exposure time 1.5 s/step. Single crystal X-ray diffraction (XRD) data were collected on a Bruker AXS KAPPA-APEX II CCD diffractometer using Mo-Kα radiation (λ = 0.71073 Å).
Data integration and reduction were performed using SaintPlus 6.01.
14 Absorption correction was performed with a multi-scan method implemented in SADABS.
15
Space groups were determined using XPREP implemented in APEX II suite. 16 Structures were solved using SHELXS-97 (direct methods) and refined using 
Conformational and computational analysis.
The conformational comparison was performed overlapping the aromatic portions of the three polymorphs of 1. Energy calculations were performed at MP2/6-311+G(d,p) level of theory within Spartan Software. 20 The molecular geometry obtained by X-ray studies was used for these analysis. 
Preparation of polymorphs and co-crystals

Syntheses of polymorphs 1b and 1c:
In a 2.5 mL glass vial, 11.7 mg of 1 (0.032 mmol) were dissolved in 1.0 mL of chloroform, then a solution of sodium acetate (2.9 mg, 0.032 mmol) in methanol (1.0 mL) was stratified on top of the solution of 1. The vial was capped and the solvents slowly evaporated through a needle in the cap. 
Synthesis of polymorphs 1b and 1c by sublimation:
The crude powdered 1a was sublimated at 80 °C under vacuum (P ~ 20 mbar). After 10 hours, a mixture of 1b and 1c crystals were collected on a glass slide fixed to the water cooled condenser. The 1c crystals completely transformed into polycrystalline 1a on standing at room temperature. Synthesis of 4 (haloprogin:bipyridyl, 2:1 ratio): In a 10 mL glass vial 400 mg (1.106 mmol) of 1 were dissolved in 5.0 mL of dichloromethane, then a solution of 4,4'-bipyridyl (84.7 mg, 0.553 mmol) in 2.= mL of dichloromethane was added. The open vial was left in the hood at room temperature. After three days, several yellowish prisms appeared at the bottom and on the walls of the vial. M. . Single crystals were obtained by seeding a quasi-saturated solution of 1 and 3a (2:1 molar ratio) in methanol with the finely ground powders obtained from the solid-state synthesis and then allowing for the slow evaporation of the solvent at room temperature. Synthesis of 5b (haloprogin:tetra n-butylammonium chloride, 2:1 ratio): 500 mg of 1 (1.383 mmol) and 192 mg of tetra n-butylammonium chloride (0.692 mmol) were ground together in a high-speed ball milling apparatus for 30 min at 30 Hz. The resulting powder was collected and analyzed by FTIR, XRPD, and DSC. M.p.: 82 °C; FTIR (selected bands): 2960, 2872, 2176, 1474, 1350, 1241, 1078, 1031, 875, 681 cm -1 .
Single crystals were obtained by seeding a quasi-saturated solution of 1 and 3b (2:1 molar ratio) in methanol with the finely ground powder obtained from the solid-state synthesis and then allowing for the slow evaporation of the solvent at room temperature.
Results and discussion
Polymorph screening
The crystal structure of 1 is unknown and it was expected that different polymorphs may be formed as several electron-donor sites, i.e., oxygen, chlorine, and π-systems, can accept XB from the iodoalkyne moiety. Several crystallization conditions were thus employed in order to explore the structural landscape of 1 and obtain different polymorphic forms. Slow evaporation of a chloroform solution of 1 afforded polymorph 1a as octahedral crystals with m.p. of 111 °C. The single crystal X-ray analysis revealed that XB plays a role in the structure of 1a (Figure 1, top) . In fact, the iodine atom functions as the XB-donor and forms a short contact with the π-electron density of the triple bond, working as the XB acceptor, of another molecule of haloprogin (symmetry operation ½-x,½+y,½-z). An infinite halogen-bonded chain is formed and propagates parallel to the crystallographic b axis (Figure 1 π-π Stacking interactions between couples of anti-parallel aromatic rings are also present with a separation of the rings centroids of 3.831 Ǻ (Figure 1, bottom) .
Looking for other polymorphic forms of 1, several organic solvents and their combinations were explored. All experiments resulted in the exclusive formation of polymorph 1a (see ESI) but when the ionic strength of the crystallization medium was drastically increased. In fact, when a chloroform solution of haloprogin was allowed to slowly diffuse into a saturated methanol solution of sodium acetate and the resulting solvents mixture was slowly evaporated at room temperature (two days), some crystals of two new polymorphs, 1b and 1c, were obtained along with massive quantities of 1a. Specifically, some rectangular needle-like crystals (1b, m.p.: 113 °C) and a few long and tiny needles (1c, m.p. 91 °C) were formed together with larger amounts of 1a (octahedral crystals, m.p. 111 °C). Interestingly, a similar mixed phase was also obtained by sublimating powders of 1a.
Single-crystal X-ray analyses demonstrated that 1a, 1b, and 1c present quite different patterns of XBs. In polymorph 1b, the iodine atom works as XB donor sites, similar to 1a, but the XB acceptor site is the para positioned chlorine atom of its centrosymmetric molecule which present the same XB pattern and a cyclic dimer is formed (Figure 2, top left) . The I···Cl distance is 3.633(2) Å (0.97% of the sum of van der Waals radii 22 (svdWr) of involved atoms) and the C-I···Cl and I···Cl-C angles are 171.71(9)°, and 103.67(11)°, respectively. These two angles are perfectly in line with the anisotropic electrostatic potentials around halogen atoms, with the iodine atom interacting through its electron poor σ-hole and the chlorine atom through its electron rich equatorial belt. Some other short contacts are present in this polymorph. Two HBs bridge two adjacent haloprogin molecules by connecting the chlorine atom of one molecule to one of the methylene hydrogens of another molecule (H3 B ···Cl1 distance is 2.82 Å, 0.96% of svdWr of involved atoms) and hydrogen-bonded cyclic dimers are formed ( Figure 2 , top right). Halogen and hydrogen-bonded cyclic dimers are connected in the overall crystal packing of polymorph 1b and produce ribbons extending along the c-axis (Figure 2 , bottom). It seems that crystals of polymorph 1c are quite unstable as, at room temperature, they convert into a powder sample of 1a. As a consequence, the collection of a complete crystallographic data set was not possible but the obtained data were enough to refine the crystal structure and have essential structural information (Table 1) . Similar to polymorphs 1a and 1b, also the crystal structure of 1c presents XBs which are here the only noncovalent interactions below the svdWr of involved atoms. The iodine atom functions as a bifurcated XB donor and interacts both with the oxygen atom and with the chlorine atom ortho to the propargyl ether moiety (Figure 3, left) . The I1···Cl1
ii (ìì=1-x.1+y,1/2-z) distance is 3.442 (4) Computational studies provided interesting pieces of information on the relative stabilities of the conformations adopted by molecule 1 in the three polymorphs. 1 Has few degrees of conformational freedom which can be identified by the two torsion angles ϕ 1 (C3-O1-C4-C5) and ϕ 2 (C2-C3-O1-C4) (Scheme 1). The superposition of the aromatic rings of molecules 1 in the conformations adopted in the three obtained polymorphs shows how in 1a and 1b the molecular geometry is almost identical with the two torsion angles that are very similar each other (Figure 4, left) . On the contrary, the haloprogin molecule in the polymorph 1c adopts a quite different conformation as shown in the Figure  4 , right. Single point calculations (MP2/6-311+G(d,p)) on the X-ray molecular structures of the three polymorphs of haloprogin revealed that the conformation adopted in 1a is the most stable (2.5 kJ/mol more stable than 1b) while the conformation of 1c is the least stable (17.1 kJ/mol less stable than 1a). These calculations and the similarity of the respective melting points, may suggest that polymorphs 1a and 1b are energetically similar although their intermolecular networks are different. The form 1a is quasi-exclusively obtained in the crystallization experiments and this may suggest that, in spite of the fact that in any haloprogin molecule there are three chlorine atoms versus one triple bond, the I···π synthon is more favoured than the I···Cl one. Definitely, the polymorph 1c is the least stable in the conditions used, as demonstrated by the small obtainable amount and by the fact that it converts into 1a with time at room temperature.
Co-crystal formation
The iodoalkynyl moiety being a robust XB donor, [7] [8] [9] [10] we have investigated the formation of co-crystals involving 1 and both neutral and anionic electron density donor partners. Here we describe the adducts 4 and 5a,b obtained when 4,4'-bipyridine (2) and tetrabutylammonium iodide (3a) or chloride (3b) are used as XB acceptors. 4 Was obtained by slow evaporation of a 2:1 mixture of the two starting materials 1 and 2 dissolved in methanol. The DSC thermogram suggested the formation of a new supramolecular entity since it showed a single and sharp melting endotherm at 118 °C, i.e., higher than the melting points of the starting compounds (2 m.p.: 109-112 °C). FTIR analysis confirmed that the supramolecular adduct formation involves the iodoalkynyl group, since the stretching band of the C≡C bond is at 2187 cm -1 in 1a and at 2178 cm -1 in the adduct 4. This red shift clearly indicates that the iodine atom is halogen-bonded to a strong electron density-donor site. The single crystal XRD analysis confirmed the formation of a 2:1 complex in which the molecule of 2 functions as a ditopic XB acceptor and interacts at either endings with two distinct molecules of 1 thanks to I···N XBs ( Figure 5 ). The asymmetric unit is composed by two almost identical but independent XB donor molecules bound to the same bipyridine unit. Both the XBs are extremely short, linear, and similar in their geometrical parameters. I···N Distances are 2.813(3) Å for I1A···N1 and 2.889(3) Å for I1B···N2 (around 80% reduction of the svdWr of the interacting atoms) and angles C1A-I1A···N1 and C1B-I1B···N2 are 177.95(10)° and 177.84(10)°, respectively.
The crystal lattice of the 4 adduct is also stabilised by other noncovalent interactions, most relevant the type-I halogenhalogen contacts occurring between two chlorine atoms [Cl3B⋅⋅⋅Cl3B iii (iii=-x,1-y,1-z), distance 3.320(2) Ǻ and C8B−Cl3B⋅⋅⋅Cl3 iii angle 127.77(10)°] and the π-π stacking between aromatic rings (with a rings centroids separations of 3.597 Ǻ).
The synthesis of co-crystals of 5a,b was carried out via mechanochemical reactions between 1 and ammonium halides 3a,b. Halide anions can work as polydentate XB acceptors and the number of formed interactions varies from one system to the other. DSC titration methods were used to determine the preferred pairing ratios between 1 and 3a,b. DSC analyses of 1:1 and 3:1 mixtures of 1 and 3a both showed multiple endothermic peaks. A new peak at 67 °C, mismatching the starting components, was shown by both mixture along with the melting of pure 3a (at 141 °C) in the 1:1 mixture and of pure 1a (at 111 °C) in the 3:1 mixture. This was suggesting that some excess starting component was present in both cases and that the preferred 1:3a pairing ratio in 5a is 2:1. Indeed, a mixture with this exact composition showed a single endothermic peak at 67 °C. A similar DSC analysis revealed that also the pairing ratio for the complex 5b (m.p.: 83 °C) was 2:1.
FTIR spectroscopy on these halogen-bonded ionic cocrystals showed red-shifted triple bond stretching modes from 2187 cm -1 in pure 1a to 2180 cm -1 in 5a and to 2175 cm -1 in 5b, suggesting the involvement of the iodoalkynyl fragment in the co-crystals formation. The observed red-shifts trend is also consistent with the chloride anion being a better XB acceptor than the iodide anion. Very few good-quality single crystals of 5a and 5b were obtained by adding finely ground powders of the complexes obtained in the mechanochemical syntheses to quasi-saturated methanol solutions of the starting compounds (2:1 molar ratio). Their single crystal structure determination confirmed the formation of a new supramolecular adduct composed by two molecules of haloprogin and one molecule of ammonium halide.
The asymmetric unit of 5a is composed by one molecule of 1 and half molecule of 3a, which lies on a twofold axis. The complex is assembled thanks to strong XBs occurring between the iodine atom of 1 and the iodide anion of the organic salt, which behaves ad a bidentate XB acceptor (Figure 6, left) . The distance between the XB donor and acceptor is 3.3977(4) Å (82% reduction of the svdWr of I and the Pauling ionic radius of I) and the C1−I1···I2 angle is 175.73(12)°, both these values indicating the occurrence of a strong XB. The halide coordination sphere is completed by four HB contacts with H atoms belonging to the cation alkyl chains.
The crystal structure of 5b ( Figure 6 , right) is similar to 5a. The chloride ion is halogen-bonded to iodine atom with a I1···Cl4 distance of 3.0427(5) Å (80% reduction of the svdWr of I and the Pauling ionic radius of Cl) and C1−I1···Cl4 angle of 176.00(4)° (Figure 6, right) . This remarkably short distance confirms that the C−I···Cl synthon is stronger that the C−I···I one, in nice agreement with the differences in melting point and red-shift of triple bond stretching modes in FTIR spectra. In this case too, the halide anion coordination sphere is completed by HB interactions involving the cation alkyl chains, but only two such interactions are present. Owing to the intrinsic difficulty of achieving relevant quantities of 1b and 1c polymorphs, here we report only the SSNMR characterization of 1a and of the three co-crystals 4, 5a, and 5b. The 13 C Cross Polarization Magic Angle Spinning (CPMAS) spectrum of 1a is characterized by a broad resonance at 14.4 ppm assigned to C1 (Figure 7 ). This carbon gives a signal at 6.97 ppm in CDCl 3 solution and at 18.58 ppm in C 6 D 5 N solution, indicating that the C1 chemical shift moves upfield when the iodine atom is halogen-bonded. 4 The observed chemical shift in 1a is in agreement with the presence of a XB between the iodine atom and the π electrons of the triple bond. While the details of the relationship between XB strength and the upfield shift of C1 remains to be established, As far as the SSNMR spectra of the ionic co-crystals 5a and 5b are concerned, the C1 signal is found at 31.6 and 33.0 ppm in 3a and 3b complexes, respectively ( Figure 7 ). These chemical shifts are consistent with the formation of C-I···Y synthons (Y=I, Cl) and they may also suggest that chloride anions are better XB acceptors than the iodide anion and that halides are better XB acceptors than neutral pyridine species.
Solid-State NMR studies
Conclusions
In summary, herein we have reported a polymorph screening and co-crystal formation study of the antifungal agent haloprogin (1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene, 1), a well-known halogenated API. We have described three polymorphs and three co-crystals involving both neutral and ionic CCFs. These are the first crystal structures reported in the CSD involving 1.
In the described cases, the 1-iodoalkyne moiety has been shown to be a very effective XB donor. In the crystallization of pure haloprogin, the iodine atom probes the accessible electron donor sites and the three obtained polymorphs result from this sampling process, the iodine atom binding to the π-electrons of the triple bond (in 1a), one chlorine atom (in 1b), and one chlorine and oxygen atom (in 1c). When more effective electron donor sites are made accessible by the presence of the CCFs 2 and 3a,b, co-crystals are formed wherein the iodine atom binds to the pyridine nitrogen (in 4) and the halide anions (in 5a,b) .
The obtained crystals have been fully characterized with various techniques (single crystal and powder X-ray crystallography, solid-state NMR, IR, and DSC), which have all shown that XB is a key interaction responsible for the adopted architectures in the described systems. The strategy reported in this paper is general and may find wide application in the design of new pharmaceutical polymorphs and co-crystals involving halogenated active pharmaceutical ingredients.
